Folid acid and hypertension
This article was originally published in The Tan Sheet
Executive Summary
"A single dose of folic acid improves cardiac and vascular sympathetic baroreceptor sensitivity" in patients with mild to moderate hypertension, a study in the Jan. 1 Journal of Cardiovascular Pharmacology says. Markus Bechir, MD, University Hospital, Zurich, et al., studied 21 male patients with the condition. After a two-week washout period, the men were randomized to either folic acid 5 mg or placebo. "Cardiac and vascular sympathetic baroreceptor functions were tested before and after a single dose of folic acid or placebo with two methods," the researchers state, suggesting folic acid "may represent a novel treatment" for complications associated with hypertension...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’
Santhera Pharmaceuticals did not provide enough evidence to demonstrate that its Duchenne muscular dystrophy drug Agamree was a cost-effective use of resources, according to draft guidance from England’s health technology assessment body, NICE.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.